Cargando…

Folic Acid Attenuates Contrast-Induced Nephropathy in Patients With Hyperhomocysteinemia Undergoing Coronary Catheterization: A Randomized Controlled Trial

Background: Hyperhomocysteinemia is a risk factor for contrast-induced nephropathy. Folic acid can attenuate such nephropathies in rats. The protective effect of folic acid against contrast-induced nephropathy has not been studied in humans. We aimed to investigate the effect of folic acid on the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Long, Shui, Xing, Tan, Fang, Li, Zexiong, Ling, Yesheng, Wu, Bingyuan, Chen, Lin, Li, Suhua, Peng, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517125/ https://www.ncbi.nlm.nih.gov/pubmed/34660712 http://dx.doi.org/10.3389/fcvm.2021.707328

Ejemplares similares

Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial
por: Huang, Zhuoshan, et al.
Publicado: (2023)

Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study
por: Li, Suhua, et al.
Publicado: (2020)

Folic acid supplementation attenuates hyperhomocysteinemia-induced preeclampsia-like symptoms in rats☆
por: Wang, Jun, et al.
Publicado: (2012)

Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
por: Huang, Zhuoshan, et al.
Publicado: (2020)

Using Text Content From Coronary Catheterization Reports to Predict 5-Year Mortality Among Patients Undergoing Coronary Angiography: A Deep Learning Approach
por: Li, Yu-Hsuan, et al.
Publicado: (2022)

The Effect of Spironolactone on the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Catheterization: Study Design and Rationale
por: Mujtaba, Alhasan, et al.
Publicado: (2018)

The role of folic acid on the hyperhomocysteinemia in the Buerger's disease (Thromboangiitis Obliterans)
por: Beigi, Ali Akbar, et al.
Publicado: (2014)

Effect of Folic Acid on Hematological Changes in Methionine-Induced Hyperhomocysteinemia in Rats
por: Ansari, M. N., et al.
Publicado: (2009)

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010)

Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization
por: Shukla, Anand N., et al.
Publicado: (2017)

Synergistic Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia
por: Peng, You, et al.
Publicado: (2018)

Left vs. right radial approach for coronary catheterization: Relation to age and severe aortic stenosis
por: Will, Maximilian, et al.
Publicado: (2022)

Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions
por: Li, Wen-hua, et al.
Publicado: (2012)

Different doses of folic acid and vitamin B12 to treat rabbits with deep venous thrombosis and hyperhomocysteinemia
por: Shu, Xiao-Jun, et al.
Publicado: (2018)

Association Between Non-Recovered Contrast-Associated Acute Kidney Injury and Poor Prognosis in Patients Undergoing Coronary Angiography
por: Zhou, Dianhua, et al.
Publicado: (2022)

Contrast-Induced Acute Kidney Injury in Patients on SGLT2 Inhibitors Undergoing Percutaneous Coronary Interventions: A Propensity-Matched Analysis
por: Hua, Rui, et al.
Publicado: (2022)

A Meta-Analysis of Folic Acid in Combination with Anti-Hypertension Drugs in Patients with Hypertension and Hyperhomocysteinemia
por: Wang, Wen-Wen, et al.
Publicado: (2017)

Atrial fibrillation increases inpatient and 4-year all-cause mortality in critically ill patients with liver cirrhosis
por: Luo, Yanting, et al.
Publicado: (2021)

Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography
por: Wang, Mian, et al.
Publicado: (2016)

Nomogram for contrast-induced acute kidney injury in patients with chronic kidney disease undergoing coronary angiography in China: a cohort study
por: Lei, Li, et al.
Publicado: (2020)

The Protective Effects of Enalapril Maleate and Folic Acid Tablets against Contrast-Induced Nephropathy in Diabetic Rats
por: Hou, Jiantong, et al.
Publicado: (2018)

Doubly bi-allelic variants of MTHFR and MTHFD1 in a Chinese patient with hyperhomocysteinemia and failure of folic acid therapy
por: Liu, Yu-Xing, et al.
Publicado: (2023)

Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography
por: Assareh, Ahmadreza, et al.
Publicado: (2016)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention
por: Zhao, Jingjing, et al.
Publicado: (2020)

Hyperhomocysteinemia Increases Risk of Metabolic Syndrome and Cardiovascular Death in an Elderly Chinese Community Population of a 7-Year Follow-Up Study
por: Liu, Chang, et al.
Publicado: (2022)

Impact of albumin infusion on prognosis of intensive care unit patients with congestive heart failure-hypoalbuminemia overlap: a retrospective cohort study
por: Li, Zexiong, et al.
Publicado: (2022)

Combining genetic risk score with artificial neural network to predict the efficacy of folic acid therapy to hyperhomocysteinemia
por: Chen, Xiaorui, et al.
Publicado: (2021)

A Predictive Model Based on a New CI-AKI Definition to Predict Contrast Induced Nephropathy in Patients With Coronary Artery Disease With Relatively Normal Renal Function
por: Mo, Hanjun, et al.
Publicado: (2021)

An unusual contrast-induced encephalopathy following percutaneous coronary intervention in patients with cerebrovascular abnormalities: A case report
por: Liao, Jiangquan, et al.
Publicado: (2022)

Effects of Remote Ischemic Pre-Conditioning to Prevent Contrast-Induced Nephropathy after Intravenous Contrast Medium Injection: A Randomized Controlled Trial
por: Belabbas, Dihia, et al.
Publicado: (2020)

Co-existing Hypertension and Hyperhomocysteinemia Increases the Risk of Carotid Vulnerable Plaque and Subsequent Vascular Event: An MR Vessel Wall Imaging Study
por: Li, Dongye, et al.
Publicado: (2022)

Postoperative central venous pressure is associated with acute kidney injury in patients undergoing coronary artery bypass grafting
por: Li, Jiale, et al.
Publicado: (2022)

Pentoxifylline and prevention of contrast-induced nephropathy: Is it efficient in patients with myocardial infarction undergoing coronary angioplasty?
por: Eshraghi, Ali, et al.
Publicado: (2016)

Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study
por: Chen, Fei, et al.
Publicado: (2018)

Methylenetetrahydrofolate Reductase Gene C677T Polymorphism–Dietary Pattern Interaction on Hyperhomocysteinemia in a Chinese Population: A Cross-Sectional Study
por: Leng, Song, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry
por: Zhang, Yunnan, et al.
Publicado: (2022)

Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
por: HE, HAIYAN, et al.
Publicado: (2014)

Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Zhu, Boqian, et al.
Publicado: (2016)

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
por: Zhang, H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t3c1mi28famvsithvdssle1oqr